[go: up one dir, main page]

WO2003033437A3 - Procede de fabrication d'inhibiteurs de la neuraminidase au moyen de la chimie combinatoire dynamique et composes ainsi obtenus - Google Patents

Procede de fabrication d'inhibiteurs de la neuraminidase au moyen de la chimie combinatoire dynamique et composes ainsi obtenus Download PDF

Info

Publication number
WO2003033437A3
WO2003033437A3 PCT/EP2002/011526 EP0211526W WO03033437A3 WO 2003033437 A3 WO2003033437 A3 WO 2003033437A3 EP 0211526 W EP0211526 W EP 0211526W WO 03033437 A3 WO03033437 A3 WO 03033437A3
Authority
WO
WIPO (PCT)
Prior art keywords
forming
neuraminidase
compounds obtained
combinatorial chemistry
functionality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/011526
Other languages
English (en)
Other versions
WO2003033437A2 (fr
Inventor
Christoph Steeneck
Alexey V Eliseev
Matthias Hochguertel
Heiko Kroth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERASCOPE AG
Original Assignee
THERASCOPE AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERASCOPE AG filed Critical THERASCOPE AG
Publication of WO2003033437A2 publication Critical patent/WO2003033437A2/fr
Publication of WO2003033437A3 publication Critical patent/WO2003033437A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des composés selon la formule I, dans laquelle la ligne en pointillé représente une double liaison présente dans l'une des deux positions possibles; R1 à R4 sont choisis indépendamment l'un de l'autre dans le groupe comprenant hydrogène, des groupes alkyle C1-C20, des groupes alcényle C2-C20, des groupes aryle C4-C20, des groupes aralkyle C5-C20 et des groupes alkaryle C5-C20, tous ces groupes pouvant contenir un ou plusieurs hétéroatomes du groupe comprenant N, O et S, et pouvant porter au moins un substituant du groupe comprenant des groupes hydroxyl et des groupes alkyle ester C1-C4; ou l'un des substituants NR1R2 et NR3R4 est un groupe guanidino de la formule NR5-C(NR6R7)=NR8, dans laquelle les substituants R5 à R8 ont indépendamment l'un de l'autre la signification donnée ci-dessus aux substituants R1 à R4. R9 est un groupe alkyle C1-C4, ou un sel ou un solvate physiologiquement acceptable de ceux-ci dans n'importe quelle forme stéréo-isomère ou des mélanges de ceux-ci dans n'importe quel rapport. L'invention concerne également un procédé de fabrication d'une bibliothèque de composants qui peuvent se lier à la neuraminidase, notamment la neuraminidase de la grippe. Ledit procédé consiste: i) à choisir plusieurs molécules portant une fonctionnalité susceptible d'interagir avec un site de liaison de la neuraminidase, lesdites molécules présentant également un groupe de liaison pouvant interagir avec d'autres groupes de liaison sous la formation de liaisons réversibles; ii) à faire réagir les molécules portant la fonctionnalité avec une molécule selon la formule I définie dans la revendication 1 en présence de la cible, dans les cas où survient une formation de liaisons réversibles entre les groupes de liaison sur la molécule I et sur les molécules portant une fonctionnalité.
PCT/EP2002/011526 2001-10-15 2002-10-15 Procede de fabrication d'inhibiteurs de la neuraminidase au moyen de la chimie combinatoire dynamique et composes ainsi obtenus Ceased WO2003033437A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32880201P 2001-10-15 2001-10-15
US60/328,802 2001-10-15
US35673102P 2002-02-15 2002-02-15
US60/356,731 2002-02-15

Publications (2)

Publication Number Publication Date
WO2003033437A2 WO2003033437A2 (fr) 2003-04-24
WO2003033437A3 true WO2003033437A3 (fr) 2003-12-18

Family

ID=26986521

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2002/011526 Ceased WO2003033437A2 (fr) 2001-10-15 2002-10-15 Procede de fabrication d'inhibiteurs de la neuraminidase au moyen de la chimie combinatoire dynamique et composes ainsi obtenus
PCT/EP2002/011520 Ceased WO2003034071A2 (fr) 2001-10-15 2002-10-15 Procede de formation d'une bibliotheque combinatoire dynamique faisant appel a une structure d'echafaudage

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/011520 Ceased WO2003034071A2 (fr) 2001-10-15 2002-10-15 Procede de formation d'une bibliotheque combinatoire dynamique faisant appel a une structure d'echafaudage

Country Status (2)

Country Link
AU (1) AU2002346915A1 (fr)
WO (2) WO2003033437A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60311879T2 (de) 2002-12-23 2007-12-20 Astex Therapeutics Ltd., Cambridge Synthese und screening von liganden mit hilfe von röntgenkristallographie
AU2004230519A1 (en) * 2003-04-11 2004-10-28 Sgx Pharmaceuticals, Inc. Compound libraries and methods for drug discovery
EP1496038A1 (fr) * 2003-07-11 2005-01-12 Therascope AG Méthode de synthèse d'une chimiothèque combinatoire dynamique faisant intervenir des nitrones
EP1496039B1 (fr) * 2003-07-11 2018-02-14 Kirschfeld, Andreas Méthode de création d'une chimiothèque combinatoire dynamique
WO2009068321A1 (fr) * 2007-11-26 2009-06-04 Forschungsverbund Berlin E.V. Criblage haut débit dirigé
DE102011117128A1 (de) * 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
JP6754997B2 (ja) 2013-08-26 2020-09-16 国立大学法人 東京大学 大環状ペプチド、その製造方法、及び大環状ペプチドライブラリを用いるスクリーニング方法
CN107325040B (zh) * 2016-04-28 2019-05-03 广州市恒诺康医药科技有限公司 环己烯类衍生物或其药学上可接受的盐及其用途
CN114315626A (zh) * 2021-12-21 2022-04-12 艾希尔（深圳）药物研发有限公司 一种奥司他韦脱烷基杂质的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031047A1 (fr) * 1997-12-12 1999-06-24 Gilead Sciences, Inc. Carboxylates de cyclohexene utilises comme inhibiteurs de neuraminidase

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
EP0765341A4 (fr) * 1994-06-16 1998-09-16 Smithkline Beecham Corp Cyclisation dirigee par matrice
US5958702A (en) * 1995-02-06 1999-09-28 Benner; Steven Albert Receptor-assisted combinatorial chemistry
DE19619373A1 (de) * 1996-05-14 1997-11-20 Hoechst Ag Neue Substanzbibliothek und damit hergestellte supramolekulare Komplexe
US20020068301A1 (en) * 1997-05-28 2002-06-06 Hung-Sen Lai Cyclic peptide libraries and methods of use thereof to identify binding motifs
CA2284459C (fr) * 1999-10-04 2012-12-11 Neokimia Inc. Synthese combinatoire de bibliotheques de composes macrocycliques utiles pour la decouverte de medicaments
EP1130009A1 (fr) * 2000-03-01 2001-09-05 Therascope AG Préparation et screening d'une bibliothèque de chimie combinatoire dynamique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031047A1 (fr) * 1997-12-12 1999-06-24 Gilead Sciences, Inc. Carboxylates de cyclohexene utilises comme inhibiteurs de neuraminidase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LEW W ET AL: "A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 8, no. 23, 1 December 1998 (1998-12-01), pages 3321 - 3324, XP004143751, ISSN: 0960-894X *

Also Published As

Publication number Publication date
WO2003034071A3 (fr) 2004-03-11
WO2003034071A2 (fr) 2003-04-24
WO2003033437A2 (fr) 2003-04-24
AU2002346915A1 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
WO2003033437A3 (fr) Procede de fabrication d'inhibiteurs de la neuraminidase au moyen de la chimie combinatoire dynamique et composes ainsi obtenus
AU3623800A (en) Methods and compositions for economically synthesizing and assembling long dna sequences
WO2004077062A3 (fr) Procede pour selectionner un compose medicamenteux d’interet potentiel
WO2007108013A3 (fr) Bioconjugues innovants en tant qu'agents therapeutiques et leur synthese
WO2003035830A3 (fr) Synthese efficace de conjugues proteines -oligonucleotides
EP1308449A3 (fr) Procedé de préparation de complexes métalliques ioniques
WO2005021786A8 (fr) Methode de sequençage d'acides nucleiques par ligature d'oligonucleotiques marques
WO2004097041A3 (fr) Methodes de criblage
EA199900821A1 (ru) Способ получения производных пиразола
WO2002077194A3 (fr) Synthese de polymeres
EP1778763B8 (fr) Procede de production de polyamides hautement ramifies
CA2447803A1 (fr) Synthese d'acide 4-phenylbutyrique
WO2002024772A3 (fr) Compositions de fluoropolymeres contenant un complexe metal-amine
WO2002086155A3 (fr) Methode permettant de realiser une reaction de synthese preferentielle d'acides nucleiques dans une ou plusieurs regions choisies d'un ou de plusieurs acides nucleiques cibles
WO2003025567A3 (fr) Production de molecules liees au support
EP2237035A3 (fr) Dérivés de taxol pour l'immunodosage du taxol
WO2006014872A3 (fr) Nouveaux procedes de synthese stereoselective d'un compose isatx247 trans
WO2004007407A3 (fr) Nouveau reactifs de marquage au fluor et de piegeage et procedes de synthese et d'utilisation correspondants
WO2003040133A1 (fr) Derive d'acide maleique et composition durcissable le contenant
BR0111317A (pt) Processo para preparar compostos, composto, sistema de catalisador, e, usos de um composto e de um sistema de catalisador
WO1997035194A3 (fr) Procede de criblage enantiomere et compositions pour ce procede
WO2002024690A3 (fr) Procede de preparation efficace d'un inhibiteur du facteur xa
WO2003052383A3 (fr) Synthese combinatoire sur reseaux
WO2003082937A3 (fr) Composition polymerisable
WO2002020435A3 (fr) Production de banques combinatoires et evaluation desdites banques par deconvolution

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP